Apple vs. Masimo: A Comprehensive Timeline Of Apple’s Patent Infringement Lawsuits

A comprehensive timeline of Masimo's legal battle with Apple over pulse oximetry technology.

• Source: Shutterstock

More from Legal & IP

US Federal Trade Commission Challenges Surmodics-Biocoat Merger Over Antitrust Concerns

 
• By 

A planned merger between medical device coating manufacturers Surmodics and Biocoat is facing an antitrust lawsuit from the US Federal Trade Commission. The FTC believes the move would create an illegal monopoly.

Court Decision On LDTs ‘Quite Realistic’ Before May Deadline, Says ACLA Attorney

 

An attorney representing the ACLA in its lawsuit to stop the US FDA’s final rule on LDTs emerged from a lengthy hearing on the case feeling ‘cautiously optimistic’ and said a decision could come before May.

Non-EU Medtech Firms May Face Suits Under New Product Liability Directive

 

The EU’s new Product Liability Directive will make it easier for European consumers to seek compensation relating to defective products even if manufacturers are based outside the bloc. Legal experts caution that this could have substantial implications for pharmaceutical companies.

Court to Decide on Rehearing for Doctor Convicted of Reusing Sinus Balloons

 
• By 

Anita Jackson is facing 25 years for device adulteration and a host of other charges. She says the trial and appeals court failed to consider her defense.

More from Policy & Regulation

European Health Data Space: Commission And Industry’s Key Principles And Priorities

 

The European Commission has published a 44-page EHDS Q&A while industry has issued a joint paper emphasizing the importance of a stakeholder forum just as the EHDS Regulation is published and is due to enter into force.

HIMSS 2025: Interview with Aneesh Chopra, Arcadia’s Chief Strategy Officer, About The Future Of Health Data, Interoperability, AI

 
• By 

Medtech Insight sat down with Arcadia's chief strategy officer Aneesh Chopra to discuss interoperability, industry standards and the future of health care data and AI.

HHS Buyout Offer Exempts FDA Reviewers And Inspectors

 

The $25,000 buyout, in addition to the early retirement program and layoffs, is intended to reduce the size of the US HHS workforce.